| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO | EVP, North America Commercial
2 companies
O'Grady Brendan P. is a CEO at ASRT, with reported holdings spanning 2 companies. Recent filings cover 1 purchase and 20 sales. Those positions are worth an estimated $3.6M at current prices.
O'Grady Brendan P.'s largest disclosed position is in ASRT as CEO, worth about $3.0M. Net of sales, the recent Form 4 record there shows accumulation of 11,706 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 12, 2019 | TEVA Teva Pharmaceutical Industries Ltd | EVP, North America Commercial | Sale+OE | 738 | $15.67 | $11,568.08 | -34.7% | |
| Mar 4, 2019 | TEVA Teva Pharmaceutical Industries Ltd | EVP, North America Commercial | Sale+OE | 1,166 | $16.88 | $19,685.93 | -45.6% | |
| Sep 18, 2018 | TEVA Teva Pharmaceutical Industries Ltd | EVP, North America Commercial | Sale+OE | 1,241 | $23.71 | $29,420.39 | -47.2% | |
| Mar 19, 2018 | TEVA Teva Pharmaceutical Industries Ltd | EVP, North America Commercial | Sale+OE | 1,179 | $17.88 | $21,078.16 | -45.9% | |
| Mar 12, 2018 | TEVA Teva Pharmaceutical Industries Ltd | EVP, North America Commercial | Sale+OE | 738 | $19.49 | $14,382.88 | -34.7% | |
| Mar 5, 2018 | TEVA Teva Pharmaceutical Industries Ltd | EVP, North America Commercial | Sale+OE | 705 | $19.38 | $13,662.90 | -33.7% |